#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma recurrent Mucopolysaccharidosis I Haemophagocytic lymphohistiocytosis Cardiac sarcoidosis Guillain-Barre syndrome Haematological malignancy Acute graft versus host disease in intestine Immune-mediated enterocolitis Cutaneous T-cell lymphoma stage II Breast cancer metastatic Gastric cancer Oropharyngeal squamous cell carcinoma Essential thrombocythaemia B-cell lymphoma Congenital leptin deficiency More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Erdheim-Chester disease – Diagnostics Breast angiosarcoma metastatic Fabry’s disease – Diagnostics Primary immunodeficiency syndrome – Trials in Disease Myxofibrosarcoma – Treatment Langerhans cell sarcoma – Basic Information Burkitt’s lymphoma – Trials in Disease X-linked lymphoproliferative syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Suvecaltamide Tenofovir Disoproxil Fumarate Autogene Cevumeran Daplusiran Nvdx3 Ecoo4 GRNA-001 L-Arginine Hydrochloride Ceftolozane INDAPAMIDE HEMIHYDRATE Autologous Chondrocytes Imetelstat Sodium Sibeprenlimab Glofitamab GOLD SODIUM THIOSULFATE Bi 3720931 AMODIAQUINE Azd5492 Colistimethate Sodium Gen1055 More therapies…

    Learn about Your Condition

    Retinal artery occlusion Procedural anxiety Glomerulonephritis membranous Peritoneal cancer index Neurofibromatosis Lyme disease Implantation complication Pulmonary alveolar haemorrhage Immune-mediated enterocolitis Malignant lymphoid neoplasm Endocarditis enterococcal Encephalitis autoimmune Penile squamous cell carcinoma Sarcoma Obsessive-compulsive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on Early Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Patent ductus arteriosus
    Investigated Drugs:
    • Sodium Chloride
    • Paracetamol
    Czechia Ireland

  • Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Cord Blood-Derived Mononuclear Cells
    France

  • Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pegunigalsidase Alfa
    Austria France Norway Spain

  • Study on the Safety and Effects of SPK-3006 for Adults with Late-Onset Pompe Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Vanglusagene Ensiparvovec
    Germany

  • Study on Sildenafil for Adults with Single Ventricle Heart Condition Post-Fontan Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Univentricular heart
    • Fontan procedure
    Investigated Drugs:
    • Sildenafil
    Poland

  • Study on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption

    Recruiting

    3 1
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden
Previous Page
1 … 9 10 11 12 13 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!